Method to evaluate the dustiness of pharmaceutical powders

被引:41
|
作者
Boundy, Maryanne [1 ]
Leith, David
Polton, Thomas
机构
[1] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA
[2] Pfizer Inc, New York, NY 10017 USA
来源
ANNALS OF OCCUPATIONAL HYGIENE | 2006年 / 50卷 / 05期
关键词
dustiness measurement; pharmaceuticals; toxic powders;
D O I
10.1093/annhyg/mel004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The trend among pharmaceutical companies to develop selective drugs of high potency has pushed the industry to consider the potential of each hazardous ingredient to become airborne. Dustiness issues are not unique to the pharmaceutical industry, but are relevant to any industry where powdered materials are mixed, transferred and handled. Interest in dustiness is also driven by concerns for worker health, the potential for plant explosions and the prevention of product loss. Unlike other industries, the pharmaceutical industry is limited by the milligram quantity of powdered material available for testing during product development. These needs have led to the development of a bench-top dustiness tester that requires only 10 mg of powder and fully contains the generated aerosol. The powder is dispersed within a 5.7 liter glass chamber that contains a respirable mass sampler and a closed-face sampler to quantify the respirable and total dust that are generated with a given energy input. The tester distinguished differences in dustiness levels of five different powders. Finer powders were dustier, and the respirable dust percentage was always less than that for total dust. Four testers have been built and evaluated using pharmaceutical grade lactose. Dustiness measurements determined using all four testers were comparable. The pharmaceutical industry uses surrogates such as lactose to represent active compounds in tests that estimate the dust concentration likely to occur in a new manufacturing operation. Differences between the dustiness of the active compound and its surrogate challenge the relevance of the surrogate tests to represent true exposures in the workplace. The tester can determine the dustiness of both the active compound and its surrogate, and the resultant ratio can help to interpret dust concentrations from surrogate tests. Further, dustiness information may allow the pharmaceutical researcher to select powder formulations that present low airborne concentrations in the workplace.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 50 条
  • [31] ASSESSMENT OF THE WETTABILITY OF PHARMACEUTICAL POWDERS
    BUCKTON, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 132 - COLL
  • [32] Microwave drying of pharmaceutical powders
    McLoughlin, CM
    McMinn, WAM
    Magee, TRA
    FOOD AND BIOPRODUCTS PROCESSING, 2000, 78 (C2) : 90 - 96
  • [33] Morphological analysis of pharmaceutical powders
    Pons, MN
    Vivier, H
    Delcour, V
    Authelin, JR
    Paillères-Hubert, L
    POWDER TECHNOLOGY, 2002, 128 (2-3) : 276 - 286
  • [34] Quantification of the compactibility of pharmaceutical powders
    Sonnergaard, Jorn M.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (03) : 270 - 277
  • [35] Suction filling of pharmaceutical powders
    Zakhvatayeva, A.
    Hare, C.
    Wu, C. Y.
    POWDER TECHNOLOGY, 2019, 355 : 438 - 448
  • [36] Flowability of moist pharmaceutical powders
    Emery, Erica
    Oliver, Jasmine
    Pugsley, Todd
    Sharma, Jitendra
    Zhou, Joe
    POWDER TECHNOLOGY, 2009, 189 (03) : 409 - 415
  • [37] COMPRESSION BEHAVIOR OF PHARMACEUTICAL POWDERS
    CHOWHAN, ZT
    CHOW, YP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1980, 5 (02) : 139 - 148
  • [38] Modeling of the porosity of pharmaceutical powders
    Masteau, JC
    Thomas, G
    JOURNAL DE CHIMIE PHYSIQUE ET DE PHYSICO-CHIMIE BIOLOGIQUE, 1997, 94 (03) : 598 - 619
  • [39] ASSESSMENT OF THE WETTABILITY OF PHARMACEUTICAL POWDERS
    BUCKTON, G
    JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY, 1993, 7 (03) : 205 - 219
  • [40] Dustiness behaviour of loose and compacted Bentonite and organoclay powders: What is the difference in exposure risk?
    Jensen, Keld Alstrup
    Koponen, Ismo Kalevi
    Clausen, Per Axel
    Schneider, Thomas
    JOURNAL OF NANOPARTICLE RESEARCH, 2009, 11 (01) : 133 - 146